Hepion Pharmaceuticals director Gary S. Stetz II files initial beneficial ownership statement
HEPA•Initial Form 3 filing
Hepion Pharmaceuticals director Gary S. Stetz II filed an initial Form 3 on July 10 for a July 1 reporting event.
Related News
Nasdaq trade halt continues <MCTA.O> reason not available at 03:28 AM
MCTA•
Nasdaq trade halt continues <NUTR.O> reason not available at 03:28 AM
NUTR•
Meta scraps AI image feature days after launch following privacy backlash
META•
GreenPower shares resume trading after BCSC lifts cease-trade order; Nasdaq listing unaffected
GP•
Nasdaq trade halt continues <EMPG.O> reason not available at 03:28 AM
EMPG•